Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1994-02-03
1998-06-09
Jones, W. Gary
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 5, 435 71, 435 72, 435 79, 435 691, 530300, 5303881, 5303872, 530350, 530333, 530403, 436500, 436548, 436818, 424 111, 536 231, C12Q 168, G01N 3353, C07K 1528, C07H 2102
Patent
active
057631646
ABSTRACT:
The present invention relates to tumor specific antigens and functional proteins of a tumor cell preparable by identifying protein presents in the tumor cell that are selectively immunogenic for tumor patients. The present invention still further provides a process of making a peptide library of tumor specific humoral antigens, a process of increasing the immunogenic specificity of a tumor-associated antigen, an assay kit for detecting the presence of an antibody immunoreactive with a tumor-specific antigen, and a process of making T cells sensitized to a tumor-specific antigen.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 5382513 (1995-01-01), Lam et al.
patent: 5532167 (1996-07-01), Cantley et al.
Beaucage, et al. Tetrahedron Letters 22: 1859-1862 (1981).
Berczi et al. "Tumor-Reactive IgE Antibodies in Plasma of Patients with Gastrointestinal Carcinomas", Cancer Immunol Immunother 14:180-184 (1983).
W. Neal Burnette "Western Blotting: Electrophoretic Transfer of Proteins from Sodium Dodecyl Sulfate--Polyacrylamide Gels to Unmodified Nitrocellulose and Radiographic Detection with Antibody and Radioiodinated Protein A", Anal. Biochem. 112:195-203 (1981).
Ceska et al. "Radioimmunosorbent Assay of Allergens", J. of Allergy and Clin. Imm. 49:1-9 (1972).
Cheever I et al. "Specific Adoptive Therapy of Established Leukemia with Syngeneic Lymphocytes Sequentially Immunized In Vivo and In Vitro and Non Specifically Expanded By Culture with Interleukin 2", J. of Immun. 126: 1318-1322 (1981).
Cheever II et al. "Augmentation of the Anti-Tumor Therapeutic Efficacy of Long-Term Cultured T Lymphocytes By In Vivo Administration of Purified Interleukin 2", J. of Med. 155:968-980 (1982) 2 Exp. Med.
Cheever III et al. "Review: Potential for Specific Cancer Therapy with Immune T Lymphocytes", J. of Biol. Resp. Mod. 3:113-127 (1984).
Cheever IV et al. "Interleukin-2 Administered In Vivo Induces the Growth and Augments the Function of Cultured T Cells In Vivo", J. of Biol. Resp. Med. 3:462-467 (1984).
Cheever V et al. "Interleukin 2 Administered In Vivo Induces the Growth of Cultured T. Cells In Vivo", J. of Imm. 132:2259-2265 (1984).
Cheever VI et al., "Interleukin 2 (IL2) Administered In Vivo: Influence of IL2 and Timing of T Cell Growth", J. of Imm. 134:3895-3899 (1985).
Cheever VII et al. "Antigen Driven Long Term Cultured T Cells Proliferate In Vivo Distribute Widely, Medicate Specific Tumor Therapy, and Persist Long Term as Functional Memory T Cells", J. Exp. Med. 163:1100-1112 (1986).
Graziani et al., "The Human dbl-proto-oncogene Product is a Cytoplasmic Phosphoprotein which is Associated with the Cytoskeletal Matrix," Oncogene, 4:823-829, 1989.
Ron et al., "Molecular Cloning and Characterization of the Human dbl Proto-oncogene: Evidence that its Overexpression is Sufficient to Transform NIH/3T3 Cells," EMBO Journal, 7:2465-2473, 1988.
Srivastava et al., "Identification of the Protein Encoded by the Human Diffuse B-cell Lymphoma (dbl) Oncogene," Proc. Natl. Acad. Sci., 83:8868-8872, 1986.
Eva et al., "The Predicted DBL Oncogene Product Defines a Distinct Class of Transforming Proteins," Proc. Natl Acad. Sci., 85:2061-2065, 1988.
Pickering et al., "Human Monoclonal Antibodies to Cytokeratins Associated with Squamous Cells Carcinoma," Clinical Immunology Immunopathology, 32:253-260, 1984.
Ioannides et al., "Cytotoxic T Cells Clones Isolated form Ovarian Tumor-Infiltrating Lymphocytes Recognize Multiple Antigenic Epitopes on Autologous Tumor Cells," Journal Immunology, 146:1700-1707, 1991.
Ben-Mahrez, "Detection of Circulating Antibodies Against c-myc Protein in Cancer Patient Sera," British Journal Cancer, 57:529-534, 1988.
Sorokine et al., "Presence of Circulating Anti-c-myb Oncogene Product Antibodies in Human Sera," International Journal Cancer, 47:665-669, 1991.
Davidoff et al., "Immune Response to p53 is Dependent upon p53/HSP70 Complexes is Breast Cancers," Proc. Natl. Aca. Sci., 89:3439-3442, 1992.
Dillner et al, PNAS 886: 3838-3841, 1989.
Van Der Bruggen et al., Science, 254: 1643-1647, 1991.
Jones W. Gary
Northwestern University
Rees Dianne
LandOfFree
Immunogenic cancer proteins and peptides and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic cancer proteins and peptides and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic cancer proteins and peptides and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2197645